San Diego, CA

Amplyx is focused on developing innovative therapies for debilitating and life-threatening systemic fungal and viral infections in patients with compromised immune systems. Amplyx is advancing programs with the potential to protect these vulnerable patients, including those with cancer and transplants, and the critically ill.

Acquired by Pfizer in April 2021



© Copyright RiverVest® All Rights Reserved.